Background/Aim: Extraordinary restrictions aimed to limit Sars-CoV-2 spreading; they imposed a total reorganization of the health-system. Oncological treatments experienced a significant slowdown. The aim of our multicentric retrospective study was to evaluate screening suspension and surgical treatment delay during COVID-19 and the impact on breast cancer presentation. Patients and Methods: All patients who underwent breast surgery from March 11, 2020 to May 30, 2020 were evaluated and considered as the Lockdown group. These patients were compared with similar patients of the previous year, the Pre-Lockdown group. Results: A total of 432 patients were evaluated; n=223 and n=209 in the Lockdown.
Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients / Vanni, G.; Tazzioli, G.; Pellicciaro, M.; Materazzo, M.; Paolo, O.; Cattadori, F.; Combi, F.; Papi, S.; Pistolese, C. A.; Cotesta, M.; Santori, F.; Caspi, J.; Chiaravalloti, A.; Muscoli, S.; Lombardo, V.; Grasso, A.; Caggiati, L.; Raselli, R.; Palli, D.; Altomare, V.; D'Angelillo, R. M.; Palombi, L.; Buonomo, O. C.. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 40:12(2020), pp. 7119-7125. [10.21873/anticanres.14741]
Delay in breast cancer treatments during the first COVID-19 lockdown. a multicentric analysis of 432 patients
Tazzioli G.Membro del Collaboration Group
;Combi F.Membro del Collaboration Group
;Papi S.Membro del Collaboration Group
;
2020
Abstract
Background/Aim: Extraordinary restrictions aimed to limit Sars-CoV-2 spreading; they imposed a total reorganization of the health-system. Oncological treatments experienced a significant slowdown. The aim of our multicentric retrospective study was to evaluate screening suspension and surgical treatment delay during COVID-19 and the impact on breast cancer presentation. Patients and Methods: All patients who underwent breast surgery from March 11, 2020 to May 30, 2020 were evaluated and considered as the Lockdown group. These patients were compared with similar patients of the previous year, the Pre-Lockdown group. Results: A total of 432 patients were evaluated; n=223 and n=209 in the Lockdown.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Delay in breast cancer treatments during the first COVID-19.pdf
Open access
Descrizione: Articolo principale
Tipologia:
Versione pubblicata dall'editore
Dimensione
134.85 kB
Formato
Adobe PDF
|
134.85 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris
